Meridith Cass is the current CEO of Nix. Meridith has also held the positions of Forbes Boston Business Council, Nix Biosensors, Stadia Ventures, VP of Business Development at Lumos Catheter Systems, Inc., Principal at Children's Hospital Boston, Associate at Atlas Venture, and Kauffman Fellows Program. Meridith Cass has also been a co-founder and CEO at Aukera Therapeutics.
Meridith Cass began their educational career at the Commonwealth School. Meridith then went on to Bryn Mawr College, where they earned an AB in math and art history. After college, they attended the Harvard Business School, where they earned their MBA. Meridith is currently a Blavatnik Fellow and Entrepreneur in Residence at the Harvard Business School. Meridith is also a Kauffman Fellow.
Some individuals on their team include Brad Wright - Director of Software & Analytics, Inga Stenta - Interim CMO, and Olivia Crozier - Marketing Manager.
Sign up to view 8 direct reports
Get started